Fallopian tube precursors of ovarian low- and high-grade serous neoplasms (Q38067435)

28 August 2017

1 reference

title

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms (English)

1 reference

28 August 2017

1 reference

Russell Vang

1

1 reference

28 August 2017

Ie-Ming Shih

series ordinal

2

1 reference

28 August 2017

Robert J Kurman

series ordinal

3

1 reference

28 August 2017

publication date

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

62

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

44-58

1 reference

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

28 August 2017

cites work

1 reference

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

21 January 2018

1 reference

Incessant ovulation--a factor in ovarian neoplasia?

21 January 2018

1 reference

Epidemiology of ovarian cancer

21 January 2018

1 reference

Origins and molecular pathology of ovarian cancer

21 January 2018

1 reference

Disabled-2 inactivation is an early step in ovarian tumorigenicity

21 January 2018

1 reference

Precursor lesions of ovarian epithelial malignancy

21 January 2018

1 reference

Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies

21 January 2018

1 reference

Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity

21 January 2018

1 reference

Serous carcinogenesis in the fallopian tube: a descriptive classification.

21 January 2018

1 reference

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

21 January 2018

1 reference

The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls.

21 January 2018

1 reference

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

21 January 2018

1 reference

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

21 January 2018

1 reference

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

21 January 2018

1 reference

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature

21 January 2018

1 reference

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

"Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer

21 January 2018

1 reference

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions

21 January 2018

1 reference

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis

21 January 2018

1 reference

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma

21 January 2018

1 reference

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

21 January 2018

1 reference

STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis

21 January 2018

1 reference

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.

21 January 2018

1 reference

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study

21 January 2018

1 reference

PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.

21 January 2018

1 reference

Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.

21 January 2018

1 reference

The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis

21 January 2018

1 reference

Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases.

21 January 2018

1 reference

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.

21 January 2018

1 reference

Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma

21 January 2018

1 reference

HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.

21 January 2018

1 reference

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives

21 January 2018

1 reference

Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions

21 January 2018

1 reference

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis

21 January 2018

1 reference

Fallopian tube correlates of ovarian serous borderline tumors

21 January 2018

1 reference

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up

21 January 2018

1 reference

K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary

21 January 2018

1 reference

The post-reproductive Fallopian tube: better removed?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12046

1 reference

28 August 2017

1 reference